Thermo Fisher Scientific (TMO) Shares Outstanding (Weighted Average) (2009 - 2026)

Thermo Fisher Scientific has disclosed Shares Outstanding (Weighted Average) across 18 years of filings, most recently posting $372.0 million for Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) fell 1.59% year-over-year to $372.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $372.0 million (down 1.59% YoY) and the FY2025 annual result came in at $377.0 million, down 1.31% from the prior year.
• Shares Outstanding (Weighted Average) eased to $372.0 million in Q1 2026, from $377.0 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $392.0 million in Q2 2022 and troughed at $372.0 million in Q1 2026.
• A 5-year average of $383.7 million and a median of $382.0 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) retreated 0.25% — and 2026, when it slipped 1.59%.
• Tracing TMO's Shares Outstanding (Weighted Average) over 5 years: stood at $392.0 million in 2022, then declined by 1.53% to $386.0 million in 2023, then slipped by 1.04% to $382.0 million in 2024, then dropped by 1.31% to $377.0 million in 2025, then slipped by 1.33% to $372.0 million in 2026.
• Business Quant data shows TMO's Shares Outstanding (Weighted Average) at $372.0 million in Q1 2026, $377.0 million in Q4 2025, and $378.0 million in Q3 2025.